BRIEF published on 06/11/2026 at 07:05, 3 months 1 day ago Curatis relève ses prévisions de croissance des revenus pour 2026 Croissance Des Revenus Marché Suisse Médicaments Curatis Holding AG Prévisions Pour 2026
BRIEF published on 06/11/2026 at 07:05, 3 months 1 day ago Curatis Raises Revenue Growth Forecast for 2026 Revenue Growth Pharmaceuticals Swiss Market Curatis Holding AG 2026 Forecast
PRESS RELEASE published on 06/11/2026 at 07:00, 3 months 1 day ago Curatis Increases Revenue Growth Guidance for 2026 Curatis Holding AG increases its revenue growth guidance for 2026 to approximately 40%, up from the previous outlook of over 25%. The growth is driven by existing and new products in the company's portfolio Revenue Growth Switzerland Curatis Holding AG Profit Hike 2026 Forecast
BRIEF published on 05/22/2026 at 18:35, 3 months 20 days ago Curatis Holding AG approuve toutes les propositions du conseil d'administration lors de son assemblée générale annuelle. Assemblée Générale Annuelle Réélection Curatis Holding AG Propositions Du Conseil D'administration Approbation De L'auditeur
BRIEF published on 05/22/2026 at 18:35, 3 months 20 days ago Curatis Holding AG Approves All Board Proposals at AGM Annual General Meeting Re-election Board Proposals Curatis Holding AG Auditor Approval
PRESS RELEASE published on 05/22/2026 at 18:30, 3 months 20 days ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors Curatis Holding AG shareholders approve all Board proposals at Annual General Meeting. Re-election of board members and positive financial year 2025 results Annual General Meeting Re-election Board Proposals Curatis Holding AG Financial Year 2025
BRIEF published on 05/22/2026 at 07:05, 3 months 21 days ago Curatis Holding AG Secures CHF 3.0 Million from Swiss Investor Private Placement Clinical Development Curatis Holding AG Corticorelin CHF 3.0 Million
BRIEF published on 05/22/2026 at 07:05, 3 months 21 days ago Curatis Holding AG obtient 3 millions de francs suisses d'un investisseur suisse Placement Privé Développement Clinique Curatis Holding AG Corticoréline 3 Millions De Francs Suisses
PRESS RELEASE published on 05/22/2026 at 07:00, 3 months 21 days ago Curatis Holding AG announces CHF 3.0 million private placement with strategic investor Curatis Holding AG announces CHF 3.0 million private placement with strategic investor for clinical development of corticorelin drug Private Placement Clinical Development Strategic Investor Curatis Holding AG Corticorelin
BRIEF published on 03/24/2026 at 07:05, 5 months 19 days ago Curatis Reports Significant Revenue Growth and Progress in Corticorelin Development Financial Results Revenue Growth FDA Approval Curatis Corticorelin
Published on 09/12/2026 at 02:35, 11 hours 9 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 44 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 39 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 19 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 44 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 14 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 29 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 34 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 59 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 29 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
